{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:33:01Z","timestamp":1761514381583},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1245\/s10434-019-07351-6","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T18:03:31Z","timestamp":1555956211000},"page":"2357-2366","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Management of Malignant Pleural Mesothelioma in the Elderly Population"],"prefix":"10.1245","volume":"26","author":[{"given":"Vivek","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney E.","family":"Wegner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan B.","family":"Ludmir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaakir","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Colonias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surbhi","family":"Grover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph S.","family":"Friedberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"key":"7351_CR1","unstructured":"National Comprehensive Cancer Network. Malignant pleural mesothelioma. Version 2.2018. \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mpm.pdf\n                    \n                  . Accessed 1 Nov 2018."},{"key":"7351_CR2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/JTO.0000000000000064","volume":"9","author":"P Bovolato","year":"2014","unstructured":"Bovolato P, Casadio C, Bille A, et al. Does surgery improve survival of patients with malignant pleural\u00a0mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients. J Thorac Oncol. 2014;9:390\u20136.","journal-title":"J Thorac Oncol"},{"key":"7351_CR3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jtcvs.2012.12.037","volume":"145","author":"DJ Sugarbaker","year":"2013","unstructured":"Sugarbaker DJ, Gill RR, Yeap BY, et al. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. J Thorac Cardiovasc Surg. 2013;145:955\u201363.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"7351_CR4","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1097\/JTO.0b013e3182288af9","volume":"6","author":"L Lang-Lazdunski","year":"2011","unstructured":"Lang-Lazdunski L, Bille A, Belcher E, et al. Pleurectomy\/decortication, hyperthermic pleural lavage with povidone-iodine followed by adjuvant chemotherapy in patients with malignant pleural mesothelioma. J Thorac Oncol. 2011;6:1746\u201352.","journal-title":"J Thorac Oncol"},{"key":"7351_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fphy.2015.00009","volume":"3","author":"TC Zhu","year":"2015","unstructured":"Zhu TC, Liang X, Kim MM, et al. An IR navigation system for pleural PDT. Front Phys. 2015;3:9.","journal-title":"Front Phys"},{"key":"7351_CR6","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1053\/j.seminoncol.2014.09.017","volume":"41","author":"CB Simone 2nd","year":"2014","unstructured":"Simone CB 2nd, Cengel KA. Photodynamic therapy for lung cancer and malignant pleural mesothelioma. Semin Oncol. 2014;41:820\u201330.","journal-title":"Semin Oncol"},{"key":"7351_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.lungcan.2015.05.014","volume":"89","author":"RA Damhuis","year":"2015","unstructured":"Damhuis RA, Khakwani A, De Schutter H, et al. Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England. Lung Cancer. 2015;89:212\u20137.","journal-title":"Lung Cancer"},{"key":"7351_CR8","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636\u201344.","journal-title":"J Clin Oncol"},{"key":"7351_CR9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","volume":"12","author":"T Treasure","year":"2011","unstructured":"Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural\u00a0mesothelioma: clinical outcomes of the\u00a0Mesothelioma\u00a0and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol. 2011;12:763\u201372.","journal-title":"Lancet Oncol"},{"key":"7351_CR10","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/S1470-2045(15)00208-9","volume":"16","author":"RA Stahel","year":"2015","unstructured":"Stahel RA, Riesterer O, Xyrafas A, et al. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomised, international, multicentre phase 2 trial. Lancet Oncol. 2015;16:1651\u20138.","journal-title":"Lancet Oncol"},{"key":"7351_CR11","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/ijc.26229","volume":"130","author":"A Marinaccio","year":"2012","unstructured":"Marinaccio A, Binazzi A, Marzio DD, et al. Pleural malignant mesothelioma epidemic: incidence, modalities of asbestos exposure and occupations involved from the Italian National Register. Int J Cancer. 2012;130:2146\u201354.","journal-title":"Int J Cancer"},{"key":"7351_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JGO.18.99800","volume":"4","author":"P Boffetta","year":"2018","unstructured":"Boffetta P, Malvezzi M, Pira E, Negri E, La Vecchia C. International analysis of age-specific mortality rates from mesothelioma on the basis of the international classification of diseases, 10th revision. J Glob Oncol. 2018;4:1\u201315.","journal-title":"J Glob Oncol"},{"key":"7351_CR13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","volume":"15","author":"K Bilimoria","year":"2008","unstructured":"Bilimoria K, Stewart A, Winchester D, Ko C. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683\u201390.","journal-title":"Ann Surg Oncol"},{"key":"7351_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","volume":"42","author":"DE Ho","year":"2011","unstructured":"Ho DE, Kosuke I, King G, Stuart EA. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42:1\u201328.","journal-title":"J Stat Softw"},{"key":"7351_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10:150\u201361.","journal-title":"Pharm Stat"},{"key":"7351_CR16","doi-asserted-by":"publisher","first-page":"e901","DOI":"10.1016\/j.cllc.2018.08.007","volume":"19","author":"V Verma","year":"2018","unstructured":"Verma V, Ahern CA, Berlind CG, et al. Survival by histologic subtype of malignant pleural mesothelioma and the impact of surgical resection on overall survival. Clin Lung Cancer. 2018;19:e901\u201312.","journal-title":"Clin Lung Cancer"},{"key":"7351_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jtcvs.2004.02.021","volume":"128","author":"DJ Sugarbaker","year":"2004","unstructured":"Sugarbaker DJ, Jaklitsch MT, Bueno R, et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg. 2004;128:138\u201346.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"7351_CR18","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","volume":"27","author":"LM Krug","year":"2009","unstructured":"Krug LM, Pass HI, Rusch VW, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol. 2009;27:3007\u201313.","journal-title":"J Clin Oncol"},{"key":"7351_CR19","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1183\/09031936.00039510","volume":"36","author":"PE Schil Van","year":"2010","unstructured":"Van Schil PE, Baas P, Gaafar R, et al. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J. 2010;36:1362\u20139.","journal-title":"Eur Respir J"},{"key":"7351_CR20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/JTO.0000000000000064","volume":"9","author":"P Bovolato","year":"2014","unstructured":"Bovolato P, Casadio C, Bille A, et al. Does surgery improve survival of patients with malignant pleural mesothelioma?: A multicenter retrospective analysis of 1365 consecutive patients. J Thorac Oncol. 2014;9:390\u20136.","journal-title":"J Thorac Oncol"},{"key":"7351_CR21","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1038\/bjc.2014.478","volume":"111","author":"A Linton","year":"2014","unstructured":"Linton A, Pavlakis N, O\u2019Connell R, et al. Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales. Br J Cancer. 2014;111:1860\u20139.","journal-title":"Br J Cancer"},{"key":"7351_CR22","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.athoracsur.2014.05.071","volume":"98","author":"O Lauk","year":"2014","unstructured":"Lauk O, Hoda MA, de Perrot M, et al. Extrapleural pneumonectomy after induction chemotherapy: perioperative outcome in 251 mesothelioma patients from three high-volume institutions. Ann Thorac Surg. 2014;98:1748\u201354.","journal-title":"Ann Thorac Surg"},{"key":"7351_CR23","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.athoracsur.2014.06.024","volume":"98","author":"RR McMillan","year":"2014","unstructured":"McMillan RR, Berger A, Sima CS, et al. Thirty-day mortality underestimates the risk of early death after major resections for thoracic malignancies. Ann Thorac Surg. 2014;98:1769\u201375.","journal-title":"Ann Thorac Surg"},{"key":"7351_CR24","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jtcvs.2015.09.121","volume":"151","author":"HF Batirel","year":"2016","unstructured":"Batirel HF, Metintas M, Caglar HB, et al. Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy. J Thorac Cardiovasc Surg. 2016;151:478\u201384.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"7351_CR25","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1093\/ejcts\/ezv403","volume":"49","author":"AJ Sharkey","year":"2016","unstructured":"Sharkey AJ, Tenconi S, Nakas A, Waller DA. The effects of an intentional transition from extrapleural pneumonectomy to extended pleurectomy\/decortication. Eur J Cardiothorac Surg. 2016;49:1632\u201341.","journal-title":"Eur J Cardiothorac Surg"},{"key":"7351_CR26","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/icvts\/ivx221","volume":"25","author":"AJ Sharkey","year":"2017","unstructured":"Sharkey AJ, Bilancia R, Tenconi S, Nakas A, Waller DA. Extended pleurectomy decortication for malignant pleural mesothelioma in the elderly: the need for an inclusive yet selective approach. Interact CardioVasc Thorac Surg. 2017;25:696\u2013702.","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"7351_CR27","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jtho.2017.08.012","volume":"12","author":"V Verma","year":"2017","unstructured":"Verma V, Ahern CA, Berlind CG, et al. National Cancer Database report on pneumonectomy versus lung-sparing surgery for malignant pleural mesothelioma. J Thorac Oncol. 2017;12:1704\u201314.","journal-title":"J Thorac Oncol"},{"key":"7351_CR28","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.athoracsur.2015.04.151","volume":"100","author":"T Williams","year":"2015","unstructured":"Williams T, Duraid H, Watson S, et al. Extended pleurectomy and decortication for malignant pleural\u00a0mesothelioma\u00a0is an effective and safe cytoreductive surgery in the\u00a0elderly. Ann Thorac Surg. 2015;100:1868\u201374.","journal-title":"Ann Thorac Surg"},{"key":"7351_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/sj.bjc.6604442","volume":"99","author":"GL Ceresoli","year":"2008","unstructured":"Ceresoli GL, Castagneto B, Zucali PA, et al. Pemetrexed plus carboplatin in\u00a0elderly\u00a0patients with malignant pleural\u00a0mesothelioma: combined analysis of two phase II trials. Br J Cancer. 2008;99:51\u20136.","journal-title":"Br J Cancer"},{"key":"7351_CR30","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.athoracsur.2011.02.062","volume":"91","author":"JS Friedberg","year":"2011","unstructured":"Friedberg JS, Mick R, Culligan M, et al. Photodynamic therapy (PDT) and the evolution of a lung sparing surgical treatment for mesothelioma. Ann Thorac Surg. 2011;91:1738\u201345.","journal-title":"Ann Thorac Surg"},{"key":"7351_CR31","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.athoracsur.2016.08.071","volume":"103","author":"JS Friedberg","year":"2017","unstructured":"Friedberg JS, Simone CB 2nd, Culligan MJ, et al. Extended pleurectomy-decortication-based treatment for advanced stage epithelial\u00a0mesothelioma\u00a0yielding a median survival of nearly three years. Ann Thorac Surg. 2017;103:912\u20139.","journal-title":"Ann Thorac Surg"},{"key":"7351_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.lungcan.2018.03.019","volume":"120","author":"V Verma","year":"2018","unstructured":"Verma V, Ahern CA, Berlind CG, et al. Facility volume and postoperative outcomes for malignant pleural mesothelioma: a National Cancer Data Base analysis. Lung Cancer. 2018;120:7\u201313.","journal-title":"Lung Cancer"},{"issue":"2","key":"7351_CR33","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.jtcvs.2018.10.039","volume":"157","author":"V Verma","year":"2019","unstructured":"Verma V, Ahern CA, Berlind CG, et al. Treatment of malignant pleural mesothelioma with chemotherapy preceding versus following surgical resection. J Thorac Cardiovasc Surg. 2019;157(2):758\u2013766.e1.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"7351_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jamcollsurg.2012.06.017","volume":"215","author":"WB Chow","year":"2012","unstructured":"Chow WB, Rosenthal RA, Merkow RP, et al. Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society. J Am Coll Surg. 2012;215:453\u201366.","journal-title":"J Am Coll Surg"},{"key":"7351_CR35","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jamcollsurg.2015.12.026","volume":"222","author":"S Mohanty","year":"2016","unstructured":"Mohanty S, Rosenthal RA, Russell MM, et al. Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society. J Am Coll Surg. 2016;222:930\u201347.","journal-title":"J Am Coll Surg"},{"key":"7351_CR36","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cllc.2016.03.002","volume":"17","author":"CJ Yang","year":"2016","unstructured":"Yang CJ, Yan BW, Meyerhoff RR, et al. Impact of age on long-term outcomes of surgery for malignant pleural mesothelioma. Clin Lung Cancer. 2016;17:419\u201326.","journal-title":"Clin Lung Cancer"},{"key":"7351_CR37","doi-asserted-by":"publisher","first-page":"e685","DOI":"10.1016\/j.cllc.2018.04.019","volume":"19","author":"SG Shaaban","year":"2018","unstructured":"Shaaban SG, Verma V, Choi JI, et al. Utilization of intensity-modulated radiation therapy for malignant pleural\u00a0mesothelioma\u00a0in the United States. Clin Lung Cancer. 2018;19:e685\u201392.","journal-title":"Clin Lung Cancer"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07351-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-07351-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07351-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T23:05:38Z","timestamp":1587423938000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-07351-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["7351"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-07351-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"18 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Vivek Verma, Rodney E. Wegner, Ethan B. Ludmir, Shaakir Hasan, Athanasios Colonias, Surbhi Grover, Joseph S. Friedberg, and Charles B. Simone II declare they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}